How the Original Polio Vaccine Was Made

Via Mercola

Story at-a-glance

  • During the 1950s, the inactivated polio vaccine created by Jonas Salk was made using rhesus monkeys that were infected with simian virus 40 (SV40), a monkey virus that was later linked to cancer in humans
  • While Salk’s polio vaccine was considered a medical triumph of its time, its manufacturing process involved the use of not only virus-contaminated monkey kidneys but also toxic compounds such as asbestos and formaldehyde
  • After mass vaccination began, reports of paralysis and death emerged, and improperly inactivated vaccine had released live virus into 100,000 doses
  • SV40 has been linked to cancers in humans; brain tumors and mesotheliomas appear to be the most common tumors associated with SV40, with some studies showing a positivity rate of up to 60%
  • SV40 promotors have also been detected in mRNA COVID-19 shots

During the 1950s, the inactivated polio vaccine created by Jonas Salk was made using rhesus monkeys that were infected with simian virus 40 (SV40), a monkey virus1 that was later linked to cancer in humans.2

Continue reading “How the Original Polio Vaccine Was Made”

THIS DAY IN HISTORY – Dr. Jonas Salk announces polio vaccine – 1953

Via History.com

8 Things You May Not Know About Jonas Salk and the Polio Vaccine - HISTORY

On March 26, 1953, American medical researcher Dr. Jonas Salk announces on a national radio show that he has successfully tested a vaccine against poliomyelitis, the virus that causes the crippling disease of polio. In 1952—an epidemic year for polio—there were 58,000 new cases reported in the United States, and more than 3,000 died from the disease. For his work in helping to eradicate the disease, which is known as “infant paralysis” because it mainly affects children, Dr. Salk was celebrated as the great doctor-benefactor of his time.

Continue reading “THIS DAY IN HISTORY – Dr. Jonas Salk announces polio vaccine – 1953”

We can’t trust the renewed “polio vaccination” push. Here’s why.

Guest Post by Kit Knightly

Last week we wrote about the new “polio outbreak” reported in the UK and around the world, and how it was likely yet another constructed narrative designed to sell yet more vaccines.

After all, it was reported that the market for polio vaccines had “stagnated” through 2021, and the first-ever vaccine granted approval under emergency use license by the World Health Organization was a new “triple-locked” polio vaccine.

In early June, the WHO granted Chinese pharmaceutical giant SINOVAC international approval for their new polio vaccine too.

So, they had brand new products, but no one to buy them.

Continue reading “We can’t trust the renewed “polio vaccination” push. Here’s why.”